InMed Reports Fiscal 2027 First-Quarter Results and Corporate Update
InMed Pharmaceuticals reported its first-quarter fiscal 2027 financial results and provided a corporate update.
Vancouver, British Columbia--(. - November 3, 2026) - InMed Pharmaceuticals Inc. NASDAQ:INM ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reported fin…